The first phase of the rollout of vaccines against coronovirus began on Tuesday with the Serum Institute of India – the manufacturer of Oxford University’s Covishield – shipping its first vials. The Union Health Ministry said in a press conference today that the inoculation program to be aired as the world’s largest bill is on track. This explained the number of vaccination campaigns.
According to the Ministry of Health, 11 million doses of the Oxford Vaccine Covishield are being purchased at Rs 200 per dose (excluding taxes). 5.5 million doses of Kovaxin developed by Hyderabad-based Bharat Biotech are also being purchased. Both of these vaccines have been approved by the country’s drug regulator for restricted emergency use.
Bharat Biotech is charging Rs 295 per dose for 38.5 lakh doses. The company, partnering with the Indian Council of Medical Research for the vaccine, will provide 16.5 lakh doses of the center free of cost.
The Union Health Ministry said today that the Center has received 54,72,000 vaccines against Coronavirus so far. 100% dose should be received by 14 January in all states / UTs.
Why only 11 million doses were ordered from the Serum Institute when the country was in high need, the ministry said, “We will waver our supply orders.”
The ministry said that vaccines developed or manufactured in India are cheaper than their western counterparts. “Two doses of Pfizer will cost around Rs 2,800; Modern two doses can cost around Rs 5,400,” it said.
Four other vaccines are being developed or manufactured in India which may be available for emergency use in the next few months.
For vaccination starting on January 16, 2360 master trainers, 61,000 program managers, 2 lakh vaccinators, 3.7 lakh other personnel have been trained so far.